Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Clinical trial NCT00020969 · TERMINATED

Trial details

NCT number: NCT00020969
Sponsor: CTI BioPharma
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms

Start date: 2001-03-01
Primary completion: 2005-01-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.